Ageing and diabetes: Implications for brain function

European Journal of Pharmacology

Volumn 441, Issue 1-2, 2002, Pages 1-14

  Biessels, Geert Jan ^a,b   Van der Heide, Lars P ^a   Kamal, Amer ^a   Bleys, Ronald L A W ^a   Gispen, Willem Hendrik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Ageing; Brain; Dementia; Diabetes mellitus; Pathogenesis

Indexed keywords

GLUTAMATE RECEPTOR; INSULIN; NIMODIPINE; PROTEIN KINASE; RECEPTOR SUBTYPE;

AGING; BRAIN DISEASE; BRAIN FUNCTION; CALCIUM HOMEOSTASIS; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; GLYCATION; HIPPOCAMPUS; HUMAN; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECOND MESSENGER;

AGING; ANIMALS; BRAIN; CALCIUM; COGNITION; DIABETES MELLITUS; HUMANS; NEURONAL PLASTICITY; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM DISEASES; SYNAPSES;

EID: 0037134269     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01486-3     Document Type: Review

References (171)

1. Non-enzymic glycation of human extracellular superoxide dismutase
2. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA)
3. MRI of the brain in diabetes mellitus
4. The use of electrophysiology for the assessment of diabetic neuropathy
5. Different voltage-dependent thresholds for inducing long-term depression and long-term potentiation in the rat visual cortex
6. Normal aging: Regionally specific changes in hippocampal synaptic transmission
7. Effects of chronic nimodipine on working memory of old rats in relation to defects in synaptosomal calcium homeostasis
8. The free radical theory of aging matures
9. Stroke in the diabetic patient
10. Stress and behavior in streptozotocin diabetic rats: Biochemical correlates of passive avoidance learning
11. The functional significance of biochemical alterations in streptozotocin-induced diabetes
12. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome
13. The calcium hypothesis of brain aging and neurodegenerative disorders: Significance in diabetic neuropathy
14. Cerebral function in diabetes mellitus
15. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats
16. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Effects of insulin treatment
17. The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats
18. Perivascular nerves of the human basal cerebral arteries: II. Changes in aging and Alzheimer's disease
19. A synaptic model of memory: Long-term potentiation in the hippocampus
20. Negative consequences of glycation
21. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
22. Neuronal excitability and conduction velocity changes in hippocampal slices from streptozotocin-treated diabetic rats
23. Chronic hyperglycaemia increases neuronal sensitivity to high potassium in hippocampal slices from streptozotocin-treated diabetic rats
24. Reduced adenosine uptake accelerates ischaemic block of population spikes in hippocampal slices from streptozotocin-treated diabetic rats
25. Autonomic control of the cerebral circulation during normal and impaired peripheral circulatory control
26. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats
27. Oxidative state of glutathione in red blood cells and plasma of diabetic patients: In vivo and in vitro study
28. Cerebrovascular nerves in old rats show reduced accumulation of 5-hydroxytryptamine and loss of nerve fibres
29. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose
30. Hypoglycemia
31. Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis
32. Endogenous adenosine modulates long-term potentiation in the hippocampus
33. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats
34. Electrophysiological alterations of the central nervous system in diabetes mellitus
35. Calcium-dependent after-hyperpolarization and learning in young and aging hippocampus
36. Functional correlates of reduced central conduction velocity in diabetic subjects
37. Regional cerebral blood flow decreases during chronic and acute hyperglycemia
38. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats
39. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study
40. Hyperinsulinemia: The missing link among oxidative stress and age-related diseases?
41. Oxidants, oxidative stress and the biology of ageing
42. Characteristics of learning and memory in streptozocin-induced diabetic mice
43. Beta-amyloid neurotoxicity
44. Involvement of hippocampal synaptic plasticity in age-related memory decline
45. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
46. Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats
47. Nonenzymatic glycation of Na, K-ATPase. Effects on ATP hydrolysis and K+ occlusion
48. Report of the expert committee on the diagnosis and classification of diabetes mellitus
49. Cognition and synaptic plasticity in diabetes mellitus
50. Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: A complication of diabetes or a consequence of treatment?
51. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type
52. Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the bio bred/Worchester diabetic rat
53. Insulin inhibition of proteasome activity in intact cells
54. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme
55. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia
56. Identification of insulin in rat brain
57. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans
58. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis
59. Changes of superoxide dismutase gene expression and activity in the brain of streptozotocin-induced diabetic rats
60. Effect of medium pH on glutathione redox cycle in cultured human umbilical vein endothelial cells
61. Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats
62. Increased diene conjugates in diabetic subjects with microangiopathy
63. Thickened cerebral cortical capillary basement membranes in diabetics
64. Gerontogenes mediate health and longevity in nematodes through increasing resistance to environmental toxins and stressors
65. Basement membrane of hypothalamus and cortex capillaries from normotensive and spontaneously hypertensive rats with steptozotocin-induced diabetes
66. Cerebral vessels in ageing and Alzheimer's disease
67. Acute effect of streptozotocin induced diabetes on bar pressing for food reward in albino rats
68. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men
69. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: Impairment of long-term potentiation and facilitation of long-term depression
70. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Interaction of diabetes and ageing
71. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat
72. Calcium hypothesis of Alzheimer's disease and brain aging
73. Brainstem auditory and visual evoked potentials in type 1 (insulin-dependent) diabetic patients
74. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons
75. Regional density of perfused capillaries and cerebral blood flow in untreated short-term and long-term streptozotocin diabetes
76. Forkhead transcription factors: New insights into protein kinase B (c-akt) signaling
77. Calcium signal prolongation in sensory neurones of mice with experimental diabetes
78. Role of mitochondrial dysfunction in calcium signalling alterations in dorsal root ganglion neurons of mice with experimentally-induced diabetes
79. Calcium-related damage in ischemia
80. Glucose transport in brain and retina: Implications in the management and complications of diabetes
81. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain
82. Reduction of nerves containing vasoactive intestinal polypeptide and serotonin, but not neuropeptide Y and catecholamine in cerebral blood vessels of the 8-week streptozotocin-induced diabetic rat
83. Increased hippocampal Ca2+ channel activity in brain aging and dementia. Hormonal and pharmacologic modulation
84. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus
85. In vivo cerebrovascular reactivity in Wistar and Fischer 344 rat strains during aging
86. Risk of dementia among persons with diabetes mellitus: A population-based cohort study
87. Diabetes mellitus: A disease of abnormal cellular calcium metabolism?
88. Daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans
89. Distribution of elements and water in peripheral nerve of streptozocin-induced diabetic rats
90. Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients
91. Antioxidant defense systems in the brains of type II diabetic mice
92. Long-term potentiation - A decade of progress?
93. Cerebrovascular disorders in patients with diabetes mellitus
94. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study
95. Hippocampal slices from long-term streptozotocin-injected rats are prone to epileptiform responses
96. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats
97. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus
98. Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction
99. Glucose regulation and cognitive functions: Relation to Alzheimer's disease and diabetes
100. Psychologic tests applied in diabetic patients
101. The effect of experimentally induced diabetes mellitus on the lipid order and composition of rat cerebral microvessels
102. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies
103. Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats
104. Visual evoked potentials in NIDDM: A longitudinal study
105. Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes
106. Aging-associated changes in human brain
107. Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats
108. Chronic cerebral hypoperfusion-induced neuropathological changes in rats
109. Synaptic activity modulates the induction of bidirectional synaptic changes in adult mouse hippocampus
110. The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans
111. Diabetes mellitus and the risk of dementia: The Rotterdam Study
112. Macroxyproteinase (M.O.P.): A 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells
113. Visual electrophysiological responses in persons with type 1 diabetes
114. Glycation of brain actin in experimental diabetes
115. Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocin-treated rats
116. Central nervous system findings in a tenth decade autopsy population
117. The P300 wave of the human event-related potential
118. Deterioration of spatial and nonspatial reference and working memory in aged rats: Protective effect of life-long calorie restriction
119. Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task
120. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric tests
121. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation
122. Pathological changes in the central and peripheral nervous system of young long-term diabetics
123. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats
124. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
125. 2 in diabetic rats
126. Neurobehavioral complications of type I diabetes. Examination of possible risk factors
127. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes
128. Effects of insulin-dependent diabetes on learning and memory efficiency in adults
129. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus
130. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow
131. Effect of insulin on central catecholamines
132. Selective vulnerability of the hippocampus in brain ischemia
133. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells
134. Insulin receptors and insulin action in the brain: Review and clinical implications
135. Model for the regulation of energy balance and adiposity by the central nervous system
136. Glutamatergic neurotransmission in aging: A critical perspective
137. Diabetes in animals: Contribution to the understanding of diabetes by study of its etiopathology in animal models
138. A comparison of cerebral blood flow during basal, hypotensive, hypoxic and hypercapnic conditions between normal and streptozotocin diabetic rats
139. Advanced glycation end-products: A review
140. Radical AGEing in Alzheimer's disease
141. Diabetes mellitus and brain atrophy: A computed tomography study in an elderly population
142. Type 2 diabetes mellitus, cognitive impairment and dementia
143. Insulin and cognitive function in an elderly population - The Rotterdam Study
144. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies
145. Genetic enhancement of learning and memory in mice
146. Diabetes mellitus preserves synaptic plasticity in hippocampal slices from middle-aged rats
147. Calcium homeostasis in intact dorsal root ganglia of diabetic and control rats
148. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
149. Regulation of rat sympathetic nerve density by target tissues and NGF in maturity and old age
150. Effect of aging on regulation of brain stem circulation during hypotension
151. Peripheral nerve function and metabolic control in diabetes mellitus
152. The role of oxidative stress in neuropathy and other diabetic complications
153. Glucose intolerance, cognitive impairment and Alzheimer's disease
154. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function
155. Diabetic neuropathies
156. Excessive non enzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats
157. Changes in calcium signalling in dorsal horn neurons in rats with streptozotocin-induced diabetes
158. Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons
159. Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons
160. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications
161. Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat
162. Glucose autoxidation and protein modification
163. Protein glycation and oxidative stress in diabetes mellitus and ageing
164. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man
165. Pathology and pathogenetic mechanisms of diabetic neuropathy
166. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
167. Selective induction of LTP and LTD by postsynaptic [Ca2+]i elevation
168. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home
169. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats
170. Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control
171. Short-term synaptic plasticity